Evidence map›Paper›PMID 30371168›Full record

ArticleJournal of the American Heart Association2018

Renin-Angiotensin-Aldosterone System, Glucose Metabolism and Incident Type 2 Diabetes Mellitus: MESA.

Joshua J Joseph, Justin B Echouffo Tcheugui, Valery S Effoe, Willa A Hsueh, Matthew A Allison, Sherita H Golden

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT04707508. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04707508 phase4completed

Investigating the Effect of Renin-Angiotensin System Inhibitors in Addition to Standard Antidiabetic Therapy on Glycemic Control in Patients With Type 2 Diabetes Mellitus: A Prospective Open-label Study

Ran2017Enrolled203Registered outcomes3Posted comparisons0ConditionsDiabetes Mellitus, Type 2ArmsMetformin, Valsartan 80 mg and metformin
Open the trial in the graph
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Combined Effects ofNutrients · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Joshua J Joseph1 Division of Endocrinology, Diabetes and Metabolism The Ohio State University Wexner Medical Center Columbus OH.
Justin B Echouffo Tcheugui2 Division of Endocrinology, Diabetes and Hypertension Brigham and Women's Hospital Harvard Medical School Boston MA.
Valery S Effoe3 Department of Medicine Morehouse School of Medicine Atlanta GA.
Willa A Hsueh1 Division of Endocrinology, Diabetes and Metabolism The Ohio State University Wexner Medical Center Columbus OH.
Matthew A Allison4 Department of Family Medicine and Public Health University of California - San Diego La Jolla CA.
Sherita H Golden5 Division of Endocrinology, Diabetes and Metabolism Johns Hopkins University School of Medicine Baltimore MD.
The Ohio State University Wexner Medical Center · USBrigham and Women's Hospital · USJohns Hopkins University · USMorehouse School of Medicine · USUniversity of California, San Diego · US

Funding

Subclinical Renal Artery Atherosclerosis, Kidney Function and HypertensionR01DK080015 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALLISON, MATTHEW A · 2009 to 2011
$1.4M
The Role of The Renin-Angiotensin-Aldosterone System, ARMC5, and Neprilysin in Glucose Metabolism among African AmericansK23DK117041 · NIDDK · OHIO STATE UNIVERSITY · PI JOSEPH, JOSHUA J · 2018 to 2022
$1.0M
NIDDK NIH HHS K23 DK117041NIDDK NIH HHS R01 DK080015
6 · The paper itself

Abstract

Background Mechanistic studies suggest that aldosterone impairs glucose metabolism. We investigated the cross-sectional associations of aldosterone and plasma renin activity with fasting plasma glucose, insulin resistance ( IR ), β-cell function, and longitudinal association with incident diabetes mellitus among adults in MESA (the multiethnic study of atherosclerosis) prospective cohort study. Methods and Results Homeostatic model assessment of IR ( HOMA 2- IR ) and HOMA 2-β were used to estimate IR and β-cell function, respectively. Incident diabetes mellitus was defined as fasting plasma glucose ≥126 mg/dL or anti-diabetic medication use at follow-up. Linear regression was used to examine cross-sectional associations of aldosterone with fasting plasma glucose, HOMA 2- IR and HOMA 2-β; Cox regression was used to estimate hazard ratios ( HR ) for incident diabetes mellitus with multivariable adjustment. There were 116 cases of incident diabetes mellitus over 10.5 years among 1570 adults (44% non-Hispanic white, 13% Chinese American, 19% Black, 24% Hispanic American, mean age 64±10 years, 51% female). A 100% increase in log-aldosterone was associated with a 2.6 mg/dL higher fasting plasma glucose, 15% higher HOMA 2- IR and 6% higher HOMA 2-β ( P<0.01). A 1- SD increase in log-aldosterone was associated with a 44% higher risk of incident diabetes mellitus ( P<0.01) with the greatest increase of 142% ( P<0.01) observed in Chinese Americans ( P for interaction=0.09 versus other ethnicities). Similar cross-sectional findings for log-plasma renin activity existed, but log-plasma renin activity was not associated with incident diabetes mellitus after full adjustment. Conclusions Aldosterone is associated with glucose homeostasis and diabetes mellitus risk with graded associations among Chinese Americans and blacks, suggesting that pleiotropic effects of aldosterone may represent a modifiable mechanism in diabetes mellitus pathogenesis with potential racial/ethnic variation.

Indexed as

Insulin ResistanceRenin-Angiotensin SystemAgedAldosteroneAsianBlack or African AmericanBlood GlucoseCohort StudiesDiabetes Mellitus, Type 2FemaleHispanic or LatinoHumansIncidenceInsulin-Secreting CellsLinear ModelsMaleAldosteroneBlood GlucoseReninaldosteronerace and ethnicityrenin angiotensin systemtype 2 diabetes mellitus

Identifiers

PMID30371168
PMCPMC6201432
OpenAlexW2891111922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.